Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... agents, vitamins, vasodilators, and drugs that may stimulate hair growth, such as finasteride and minoxidil," scientists in Brazil report. "We report two cases of ...
2009 NOV 23 ... with male-pattern hair loss, effective medical therapies that are FDA-approved include finasteride, a prescription oral medication, and minoxidil 2% and 5%, topical solutions that are ...
2009 NOV 16 ... Trial, a study of 18,882 men from around the U.S. that demonstrated that the drug finasteride reduces a man's risk of prostate cancer by 24.8 percent. In contrast to ...
2009 JUN 15 ... 5 alpha-reductase seems to explain these effects of D-004."
"Finasteride, an inhibitor of 5 alpha-reductase used to treat benign prostate hyperplasia (BPH), has ...
2009 SEP 28 ... prevalence of cancer compared with placebo in the Prostate Cancer Prevention Trial, finasteride was associated with a higher prevalence of high-grade disease. This observation was ...
2009 NOV 2 ... prostatic tissue to localized prostate cancer. The efficacy of 5AR2 monotherapy with finasteride alone or in combination with an androgen receptor antagonist on more final outcome ...
2009 SEP 7 ... Data detailed in 'Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial' have been ...
2009 NOV 16 ... this study was to further investigate the metabolism of the 5 alpha-reductase inhibitor, finasteride, and to identify previously unknown phase I and phase II metabolites in vitro and in ...
2009 JUL 13 ... assess a man's risk of prostate cancer, and prevention strategies, including the use of finasteride, a drug currently used for the treatment of urinary symptoms related to prostate ...
2009 AUG 31 ... According to recent research from Zagreb, Croatia, "Finasteride has been recognized as a drug suitable for the chemoprevention of prostate cancer (PC) ...
2009 JUN 8 ... "To investigate the clinical efficacy and safety of the finasteride (5 mg/day) plus flutamide (125 mg/day) combination therapy in unselected women with ...
2009 NOV 27 ... death in the brain of late gestation fetal sheep after inhibition of AP synthesis using finasteride, a 5 alpha-reductase type 2 (5 alpha-R2) inhibitor. Catheters were implanted in fetal ...
2009 JUL 13 ... clinical progression was significantly reduced after 4.5 years with combination therapy (finasteride/doxazosin) in comparison with either monotherapy, while the ongoing CombAT trial ...
2009 SEP 21 ... A-ring is mediated in humans by steroid 5 alpha- or 5 beta-reductase." "Finasteride is a mechanism-based inactivator of 5 alpha-reductase type 2 with subnanomolar affinity ...
2009 AUG 24 ... the 3 large scale trials SELECT (testing selenium and vitamin E), PCPT (testing finasteride) and REDUCE (testing dutasteride). The initial results of SELECT have now been reported ...
2009 JUL 20 ... have faced a dilemma about whether to treat men at risk of prostate cancer with the drug finasteride. On one hand, the drug had been shown to prevent cancer in about one of every four ...
2009 SEP 7 ... LLLT may be a promising treatment option for patients who do not respond to either finasteride or minoxidil, and who do not want to undergo hair transplantation. This technology ...
2009 JUN 1 ... A significantly greater proportion of patients using multiple medications and finasteride were adherent with any benign prostatic hyperplasia medication (62% and 55%, ...
2009 AUG 3 ... A report, 'Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis ...
